In summary, we have validated the function of PAK3 and SGK2 lentiviral shRNAs in the knockdown of PAK3 and SGK2 gene expression, and also observed viability loss of HPV+ cervical cancer cells (HeLa and CaSki) mediated by the lentiviral shRNAs. This evidence concerns the gene PAK3 and cervical carcinoma.